Rb Antibody

About the Target

The retinoblastoma protein (pRb) is a key regulator of numerous biological pathways that govern essential cellular processes such as cell growth, cell-cycle checkpoints, differentiation, senescence, self-renewal, DNA replication, genomic stability, and apoptosis. pRb contains three distinct binding domains that interact with various regulatory proteins, including the E2F transcription factor family, c-Abl tyrosine kinase, and proteins with the conserved LXCXE motif. The activity of pRb is primarily regulated through post-translational modifications, with phosphorylation being the most significant. Depending on the literature source, RB may also be discussed as Human Retinoblastoma Protein and Retinoblastoma-associated protein.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following RB across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

RB is commonly interpreted in the context of cell cycle and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RB. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RB reflect biology rather than handling. When interpreting RB, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep RB trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.